Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-01-22T09:00:51.108Z Has data issue: false hasContentIssue false
  • English
  • Français

Vasopressin and memory: improvement in normal short-term recall and reduction of alcohol-induced amnesia

Published online by Cambridge University Press:  09 July 2009

Keith Millar ,
William J. Jeffcoate  and
Cristine P. Walders
Keith Millar
Affiliation:
Behavioural Sciences Section, Department of Psychiatry, University Hospital and Medical School, Nottingham
William J. Jeffcoate
Affiliation:
Department of Medicine, City Hospital, Nottingham
Cristine P. Walders*
Affiliation:
Behavioural Sciences Section, Department of Psychiatry, University Hospital and Medical School, Nottingham
*
* Addresses for correspondence: Dr K. Millar, Behavioural Sciences Group, Universityof Glasgow, 4 Lilybank Gardens, Glasgow G12 8QQ.; or Dr W. J. Jeffcoate, Department of Medicine, City Hospital, Nottingham.
Get access Rights & Permissions [Opens in a new window]

Synopsis

The vasopressin analogue 1-desamino-8-D-arginine vasopressin (DDAVP) has been shown in healthy male volunteers to cause significant improvement in short-term memory and to reduce alcohol-induced amnesia. There was no significant effect upon semantic retrieval or simple reaction time. It was concluded that vasopressin benefited the initial processes of consolidation and learning, while the reduction of the amnesic effects of alcohol may support the contentions of other authors that the peptide improves memory in states of mild amnesia.

Type
Research Article
Information
Psychological Medicine , Volume 17 , Issue 2 , May 1987 , pp. 335 - 341
Copyright
Copyright © Cambridge University Press 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Armitage, P. & Hills, M. (1982). The two-period crossover trial. The Statistician 31, 119–131.CrossRefGoogle Scholar
Baddeley, A. D. (1976). The Psychology of Memory. Harper & Row: New York.Google Scholar
Battig, W. F. & Montague, W. E. (1969). Category norms for verbal items in 56 categories: a replication and extension of the Connecticut Category Norms. Journal of Experimental Psychology (Monograph) 80, 3 part 2.Google Scholar
Beckwith, B. E., Petros, T., Kanaan-Beckwith, S., Couk, D. I. & Haug, R. J. (1982). Vasopressin analog (DDAVP) facilitates concept learning in human males. Peptides 3, 627–630.CrossRefGoogle ScholarPubMed
Beckwith, B. E., Couk, D. I. & Till, T. S. (1983). Vasopressin analog influences the performance of males on a reaction time task. Peptides 4, 707–709.CrossRefGoogle ScholarPubMed
Eisenberg, J., Chazan-Gologorsk, S., Hattab, J. & Belmaker, R. H. (1984). A controlled trial of vasopressin treatment of childhood learning disorder. Biological Psychiatry 19, 1137–1141.Google ScholarPubMed
Fehm-Wolfsdorf, G., Born, J., Voigt, K-H. & Fehm, H. L. (1984). Human memory and neurohypophyseal hormones: opposite effects of vasoprcssin and oxytocin. Psychoneuroendocrinology 9, 285–292.CrossRefGoogle ScholarPubMed
Fehm-Wolfsdorf, G., Born, J., Elbert, T., Voigt, K-H. & Fehm, H. L. (1985). Vasopressin does not enhance human memory a study in human twins. Peptides 6, 297–300.CrossRefGoogle Scholar
Fewtrell, D., House, A. O., Jamie, P. F., Oates, M. R. & Cooper, J. E. (1982). Effects of vasopressin on memory and new learning in a brain-injured population. Psychological Medicine 12, 423–425.CrossRefGoogle Scholar
Franceschi, M., Tancredi, O., Savio, G. &Smirne, S.(1982). Vasopressin and physostigmine in the treatment of amnesia. European Neurology 21 388–391.CrossRefGoogle ScholarPubMed
Graf, P., Squire, L. R. & Mandler, G. (1984). The information that amnesic patients do not forget. Journal of Experimental Psychology: Learning, Memory and Cognition 10, 164–178.Google Scholar
Hills, M. & Armitage, P. (1979). The two-period crossover clinical trial. British Journal of Clinical Pharmacology 8, 7–20.CrossRefGoogle Scholar
Jenkins, J. S., Mather, H. M. & Coughlan, A. K. (1982). Effect of desmopressin on normal and impaired memory. Journal of Neurology, Neurosurgery and Psychiatry 45, 830–831.CrossRefGoogle ScholarPubMed
Jennekens-Schinkel, A., Wintzen, A. R. & Lanser, B. K. (1985). A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man. Progress in Neuro Psychopharmacology and Biological Psychiatry 9, 273–284.CrossRefGoogle ScholarPubMed
Jolles, J. (1983). Vasopressin-like peptides and the treatment of memory disorders in man. In The Neurohypophysis: Structure, Function and Control (ed. Cross, B. A. and Leng, G.), Progress in Brain Research 60, 169–182.CrossRefGoogle Scholar
Laczi, F., Valkusz, Zs., Laszlo, F. A., Wagner, A., Jardanhazy, T., Szasz, A., Szilard, J. & Telegdy, G. (1982). Effects of lysinevasopressin and l-deanimo-8-D-arginine vasopressin on memory in healthy individuals and diabetes insipidus patients. Psychoneuroendocrinology 7, 185–193.CrossRefGoogle ScholarPubMed
Laczi, F., Van Ree, J. M., Wagner, L., Valkusz, Zs., Jardanhazy, T., Kovacs, G. L., Telegdy, G., Szilard, J., Laszlo, F. A. & De Wied, D. (1983). Effects of desglycinamide-arginine-vasopressin (DGAVP) on memory in diabetes insipidus patients and non-diabetic subjects. Acta Endocrinologica 102, 205–212.Google ScholarPubMed
Legros, J. J., Gilot, P., Seron, X., Claessens, J., Adam, A., Moeglen, J. M., Audibert, A. & Berchier, P. (1978). Influence of vasopressin on learning and memory. Lancet i, 41–42.CrossRefGoogle Scholar
Meudell, P. R. & Mayes, A. R. (1984). Patterns of confidence loss in the cued recall of normal people with attenuated recognition memory: their relevance to a similar amnesic phenomenon. Neuropsychologia 22, 41–54.CrossRefGoogle ScholarPubMed
Millar, K. (1979). Word recognition in loud noise. Acta Psychologica 43, 225–237.CrossRefGoogle ScholarPubMed
Millar, K. (1983). Clinical trial design: the neglected problem of asymmetrical transfer in crossover trials. Psychological Medicine 13, 867–873.CrossRefGoogle Scholar
Millar, K. (1986). Psychomotor tasks and recovery from anesthesia. Anesthesia and Analgesia 65, 543.CrossRefGoogle ScholarPubMed
Millar, K. & Wilkinson, R. T. (1981). The effects upon vigilance and reaction speed of the addition of ephedrine hydrochloride to chlorpheniramine maleate. European Journal of Clinical Pharmacology 20, 351–357.CrossRefGoogle ScholarPubMed
Millar, K., Styles, B. C. & Wastell, D. G. (1980). Time of day and retrieval from long-term memory. British Journal of Psychology 71, 407–414.CrossRefGoogle Scholar
Nebes, R. D., Reynolds, C. F. III & Horn, L. C. (1984). The effect of vasopressin on memory in the healthy elderly. Psychiatry Research 11, 49–59.CrossRefGoogle ScholarPubMed
Oliveros, J. C., Jandali, M. K., Timsit-Berthie, M., Remy, R., Benghezal, A., Audibert, A. & Moeglen, J. M. (1978). Vasopressin in amnesia. Lancet i, 42.CrossRefGoogle Scholar
Poulton, E. C. & Edwards, R. S. (1979). Asymmetric transfer in within-subjects experiments on stress interactions. Ergonomics 22, 945–961.CrossRefGoogle ScholarPubMed
Poulton, E. C. & Freeman, P. R. (1966). Unwanted asymmetrical transfer effects with balanced experimental designs. Psychological Bulletin 66,1–8.CrossRefGoogle ScholarPubMed
Sternberg, S. (1969). Memory-scanning: mental processes revealed by reaction-time experiments. American Scientist 57, 421–457.Google ScholarPubMed
Sternberg, S. (1975). Memory-scanning: new findings and current controversies. Quarterly Journal of Experimental Psychology 27, 1–32.CrossRefGoogle Scholar
Weingartner, H., Gold, P., Ballenger, J. C., Smallberg, S. A., Summers, R., Rubinow, D. R., Post, R. M. & Goodwin, F. K. (1981). Effects of vasopressin on human memory functions. Science 211, 601–603.CrossRefGoogle ScholarPubMed
Wilkinson, R. T. (1969). Some factors influencing the effect of environmental stressors on performance. Psychological Bulletin 72, 260–272.CrossRefGoogle ScholarPubMed
Wimersma Greidanus, Tj. B. van, Ree, J. M. van & De Weid, D. (1983). Vasopressin and memory. Pharmacology and Therapeutics 20, 437–458.CrossRefGoogle ScholarPubMed
Winer, B. J. (1970). Statistical Principles in Experimental Design. McGraw-Hill: London.Google Scholar